Commercializing USDA Innovations Via Public-Private Partnerships - PowerPoint PPT Presentation

1 / 12
About This Presentation
Title:

Commercializing USDA Innovations Via Public-Private Partnerships

Description:

Commercializing USDA Innovations Via Public-Private Partnerships June Blalock Coordinator, Technology Licensing Program USDA, Agricultural Research Service – PowerPoint PPT presentation

Number of Views:137
Avg rating:3.0/5.0
Slides: 13
Provided by: nps1150
Category:

less

Transcript and Presenter's Notes

Title: Commercializing USDA Innovations Via Public-Private Partnerships


1
Commercializing USDA Innovations Via
Public-Private Partnerships
  • June Blalock
  • Coordinator, Technology Licensing Program
  • USDA, Agricultural Research Service
  • Office of Technology Transfer
  • djb_at_ars.usda.gov

2
Overview
  • Quick review of Federal technology transfer
    legislation
  • Summary of USDA technology transfer goals and
    policies
  • Role of private sector technology transfer
    partners
  • Factors affecting agricultural biotechnology
    partnerships

3
U.S. Technology Transfer Legislation
  • Bayh-Dole Act, 1980
  • Stevenson-Wydler Act, 1980
  • Federal Technology Transfer Act, 1986
  • National Technology Transfer and Advancement Act,
    1996
  • Technology Transfer Commercialization Act, 2000

4
37 CFR 404.2
  • It is the policy and objective of (this
    regulation) to use the patent system to promote
    the utilization of inventions arising from
    federally supported research or development.

5
37 CFR 404.2, paraphrased
  • A federally owned invention should be protected
    when a private sector partner is needed to
    achieve technology transfer
  • AND
  • that partner requires some scope of exclusivity
    to protect the capital investments needed to
    commercialize the invention.

6
USDA Technology Transfer Goals
  • Use the patent system to facilitate technology
    transfer
  • Provide an incentive for investments by the
    private sector
  • Support small business enterprises and
    entrepreneurs
  • Support investments by U.S. businesses in
    international markets

7
USDA Technology Transfer Policies
  • Patenting decisions are based on technology
    transfer requirements.
  • USDA does not require licenses for research only
    use of USDA inventions.
  • Most licenses are exclusive or partially
    exclusive.
  • Exclusive licenses for protected plant varieties
    reserve the right to make the licensed varieties
    available to third parties for research and
    breeding.
  • Scientists are promoted based on the IMPACT of
    their research.

8
Role of Private Sector Partners in Transferring
Public Sector Innovations
  • Make investments in the development and marketing
    of licensed products and services
  • Make licensed products and services widely
    available
  • Provide the complementary assets required for
    commercialization e.g., manufacturing
    facilities, marketing and distribution capacity,
    investment capital, product registration
    expertise

9
Selected USDA Technology Transfer Data for FY 2003
  • Active CRADAs 229
  • U.S. patent applications filed 60
  • U.S. patents issued 64
  • Active patent licenses 270
  • Licenses generating earned
  • royalty income 56
  • Total license revenues 2.3 million
  • Median earned royalty income 3,102

10
Examples of Licensed USDA Technologies
  • U.S. Patent No. 6,261,790, Monoclonal antibodies
    and antibody cocktail for detection of prion
    protein as an indication of transmissible
    spongiform encephalopathies
  • U.S. Patent No. 5,689,054, Low phytic acid
    mutants and selection thereof
  • U.S. Patent No. 5,676,994,Non-separable
    starch-oil compositions and U.S. Patent No.
    5,882,713, Non-separable compositions of starch
    and water-immiscible organic materials
  • U.S. Patent No. 5,705,030, Fiber and fiber
    products produced from feathers
  • U.S. Patent No. 6,083,498, Chemical attractants
    for yellowjackets and paper wasps

11
Factors Affecting the Partnership Value of
Agricultural Biotechnology Innovations
  • Consumer acceptance of agbiotech products
  • Industry consolidation
  • Biosafety regulations and liabilities
  • International trade agreements and enforcement
  • IPR availability, enforcement and freedom to
    operate
  • Advances in tools and technology

12
Complementary Assets Required for Agbiotech
Innovations
  • Facilities for propagation/seed increase and
    field trials
  • Access to markets and distribution capacity
  • Expertise in local biosafety regimes
  • Technical expertise in variety selection, trait
    stability, product QC
  • Investment capital
Write a Comment
User Comments (0)
About PowerShow.com